Skip to main content
InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.490
+0.150 (11.19%)
At close: Dec 20, 2024, 4:00 PM
1.480
-0.010 (-0.67%)
After-hours: Dec 20, 2024, 4:49 PM EST

InterCure Revenue

InterCure had revenue of 62.87M ILS in the quarter ending June 30, 2024, a decrease of -38.63%. This brings the company's revenue in the last twelve months to 272.67M, down -34.26% year-over-year. In the year 2023, InterCure had annual revenue of 355.55M, down -8.52%.

Revenue (ttm)
272.67M ILS
Revenue Growth
-34.26%
P/S Ratio
n/a
Revenue / Employee
1,009,896 ILS
Employees
270
Market Cap
63.75M USD

Revenue Chart

* This company reports financials in ILS.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023355.55M-33.13M-8.52%
Dec 31, 2022388.68M169.01M76.93%
Dec 31, 2021219.68M154.64M237.78%
Dec 31, 202065.04M56.11M628.60%
Dec 31, 20198.93M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.09B
Agenus 160.43M
Rockwell Medical 98.92M
OptiNose 75.67M
Burning Rock Biotech 72.83M
Cryo-Cell International 31.84M
Cue Biopharma 9.53M
Revenue Rankings

INCR News

More News